| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0062 | 0.9 |